An anti-inflammatory diet, tested in a pilot study of patients with relapsing-remitting (RR) or primary-progressive (PP) MS, was effective in reducing inflammation, as evidenced by the decrease in the active forms of MMP-9 (matrix metalloproteinase-9, or gelatinase B) [27]. The gene discussed is MMP9; the disease is myeloid sarcoma.